| Nov 24, 2025 |
Nov 25, 2025 |
Anderson Robert Eugene Jr
|
Director |
Buy |
91.3
|
+8,600
|
100.00%
|
✗
|
$24.9K |
| Nov 20, 2025 |
Nov 24, 2025 |
Barry Richard
|
CEO |
Buy |
97.5
|
+150,000
|
19.03%
|
✗
|
$414K |
| Nov 19, 2025 |
Nov 20, 2025 |
Barry Richard
|
CEO |
Buy |
95.0
|
+73,385
|
10.27%
|
✗
|
$201.8K |
| Oct 21, 2025 |
Oct 22, 2025 |
Bir Dawn Carter
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 22, 2025 |
Bir Dawn Carter
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 30, 2025 |
Oct 2, 2025 |
Cook Robert Christopher
|
COO |
Buy |
91.3
|
+13,725
|
100.00%
|
✗
|
$39.9K |
| Sep 22, 2025 |
Sep 23, 2025 |
Barry Richard
|
CEO |
Buy |
78.8
|
+7,172
|
1.01%
|
✗
|
$16.4K |
| Sep 18, 2025 |
Sep 22, 2025 |
Barry Richard
|
CEO |
Buy |
97.5
|
+237,941
|
50.67%
|
✗
|
$534.7K |
| May 23, 2025 |
Jul 16, 2025 |
SCANNON PATRICK J MD PHD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2025 |
May 27, 2025 |
Anderson Robert Eugene Jr
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2025 |
May 27, 2025 |
Gravier Pierre
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2025 |
May 27, 2025 |
GUSSIN ROBERT Z
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2025 |
May 27, 2025 |
Nicaise Claude
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2025 |
May 27, 2025 |
O DONNELL MICHAEL J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 17, 2025 |
Apr 21, 2025 |
Schoen Eric
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 17, 2025 |
Apr 21, 2025 |
Barry Richard
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 17, 2025 |
Apr 21, 2025 |
Nassif Freda
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 17, 2025 |
Apr 21, 2025 |
Cook Robert Christopher
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 29, 2024 |
Dec 3, 2024 |
Kupiec James William
|
Chief Medical Officer |
Sell |
26.3
|
-4,000
|
-100.00%
|
✗
|
$15.5K |
| Nov 29, 2024 |
Dec 3, 2024 |
Schoen Eric
|
CFO |
Sell |
22.5
|
-61,800
|
-84.31%
|
✗
|
$238.5K |
| Nov 18, 2024 |
Nov 20, 2024 |
Landen Jaren
|
Chief Clinical Dev. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 20, 2024 |
Landen Jaren
|
Chief Clinical Dev. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 18, 2024 |
Nov 20, 2024 |
Nassif Freda
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 20, 2024 |
Nassif Freda
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2024 |
Oct 1, 2024 |
Barry Richard
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 9, 2024 |
Schoen Eric
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 9, 2024 |
Cook Robert Christopher
|
SVP & General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 6, 2024 |
Sep 9, 2024 |
Kupiec James William
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2024 |
May 22, 2024 |
BARBIER REMI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2024 |
May 22, 2024 |
Schoen Eric
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2024 |
May 22, 2024 |
Cook Robert Christopher
|
SVP & General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2024 |
May 22, 2024 |
Kupiec James William
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2024 |
May 16, 2024 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
GUSSIN ROBERT Z
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
O DONNELL MICHAEL J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
Barry Richard
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
SCANNON PATRICK J MD PHD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
Anderson Robert Eugene Jr
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
Gravier Pierre
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
Nicaise Claude
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 26, 2024 |
Apr 30, 2024 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 23, 2024 |
Apr 25, 2024 |
Barry Richard
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 18, 2024 |
Apr 22, 2024 |
Kupiec James William
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 17, 2024 |
Apr 17, 2024 |
Schoen Eric
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 6, 2023 |
Dec 8, 2023 |
Nicaise Claude
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 8, 2023 |
Nicaise Claude
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 6, 2023 |
Dec 7, 2023 |
Gravier Pierre
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 6, 2023 |
Dec 7, 2023 |
Anderson Robert Eugene Jr
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 7, 2023 |
Gravier Pierre
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 7, 2023 |
Anderson Robert Eugene Jr
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2023 |
Oct 4, 2023 |
Schoen Eric
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2023 |
Oct 4, 2023 |
Cook Robert Christopher
|
SVP & General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2023 |
Oct 4, 2023 |
Kupiec James William
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2023 |
Oct 4, 2023 |
BARBIER REMI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 23, 2023 |
Aug 24, 2023 |
ROBERTSON SANFORD
|
Director |
Buy |
90.0
|
+30,000
|
2.89%
|
✗
|
$523.5K |
| Aug 21, 2023 |
Aug 23, 2023 |
Barry Richard
|
Director |
Buy |
92.5
|
+18,477
|
6.72%
|
✗
|
$307.9K |
| Jun 12, 2023 |
Jun 12, 2023 |
SCANNON PATRICK J MD PHD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2023 |
May 25, 2023 |
BARBIER REMI
|
CEO |
Sell |
17.5
|
-57,268
|
-4.88%
|
✗
|
$1.4M |
| May 10, 2023 |
May 10, 2023 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 4, 2023 |
May 8, 2023 |
SCANNON PATRICK J MD PHD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 4, 2023 |
May 8, 2023 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 4, 2023 |
May 8, 2023 |
O DONNELL MICHAEL J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 4, 2023 |
May 8, 2023 |
GUSSIN ROBERT Z
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 4, 2023 |
May 8, 2023 |
Barry Richard
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2023 |
May 2, 2023 |
GUSSIN ROBERT Z
|
Director |
Buy |
95.0
|
+7,077
|
199.92%
|
✗
|
$165.2K |
| Mar 7, 2023 |
Mar 8, 2023 |
O DONNELL MICHAEL J
|
Director |
Sell |
22.5
|
-5,139
|
-42.78%
|
✗
|
$129.5K |
| Mar 6, 2023 |
Mar 8, 2023 |
Barry Richard
|
Director |
Buy |
100.0
|
+88,841
|
47.72%
|
✗
|
$2.3M |
| Jun 7, 2022 |
Feb 7, 2023 |
BARBIER REMI
|
CEO |
Neutral |
27.5
|
-57,143
|
-5.00%
|
✗
|
- |
| Jan 31, 2022 |
Jan 3, 2023 |
FRIEDMANN NADAV
|
Chief Medical Officer |
Neutral |
27.5
|
-1,000
|
-1.25%
|
✗
|
- |
| Oct 28, 2022 |
Oct 31, 2022 |
Cook Robert Christopher
|
SVP & General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 31, 2022 |
Cook Robert Christopher
|
SVP & General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2022 |
Oct 3, 2022 |
FRIEDMANN NADAV
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 8, 2022 |
Sep 12, 2022 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 23, 2022 |
Aug 25, 2022 |
Barry Richard
|
Director |
Buy |
97.5
|
+36,159
|
24.11%
|
✗
|
$860.2K |
| Aug 23, 2022 |
Aug 24, 2022 |
Kupiec James William
|
Chief Clinical Dev. Officer |
Buy |
95.0
|
+2,500
|
100.00%
|
✗
|
$61.1K |
| Aug 12, 2022 |
Aug 16, 2022 |
Schoen Eric
|
CFO |
Buy |
91.3
|
+2,500
|
12.95%
|
✗
|
$49.9K |
| Aug 12, 2022 |
Aug 16, 2022 |
ROBERTSON SANFORD
|
Director |
Buy |
100.0
|
+100,000
|
10.81%
|
✗
|
$2.1M |
| Jun 6, 2022 |
Jun 7, 2022 |
BARBIER REMI
|
CEO |
Sell |
17.5
|
-54,720
|
-4.57%
|
✗
|
$1.5M |
| May 27, 2022 |
May 31, 2022 |
FRIEDMANN NADAV
|
Chief Medical Officer |
Sell |
20.0
|
-24,569
|
-25.80%
|
✗
|
$655K |
| Apr 25, 2022 |
Apr 25, 2022 |
BARBIER REMI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 29, 2022 |
GUSSIN ROBERT Z
|
Director |
Sell |
22.5
|
-4,024
|
-32.36%
|
✗
|
$160.9K |
| Mar 25, 2022 |
Mar 28, 2022 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 5, 2021 |
Feb 3, 2022 |
Schoen Eric
|
CFO |
Neutral |
27.5
|
-8,000
|
-29.30%
|
✗
|
- |
| Mar 24, 2021 |
Feb 3, 2022 |
FRIEDMANN NADAV
|
Chief Medical Officer |
Neutral |
27.5
|
-1,200
|
-1.75%
|
✗
|
- |
| Sep 15, 2021 |
Sep 21, 2021 |
GUSSIN ROBERT Z
|
Director |
Sell |
22.5
|
-1,746
|
-26.02%
|
✗
|
$76.7K |
| Jul 20, 2021 |
Jul 20, 2021 |
BARBIER REMI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 14, 2021 |
Barry Richard
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 27, 2021 |
May 28, 2021 |
BARBIER REMI
|
CEO |
Sell |
17.5
|
-53,965
|
-4.76%
|
✗
|
$3M |
| Mar 30, 2021 |
Mar 31, 2021 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 17, 2021 |
Mar 18, 2021 |
FRIEDMANN NADAV
|
Chief Medical Officer |
Sell |
17.5
|
-23,996
|
-25.96%
|
✗
|
$1.5M |
| Mar 16, 2021 |
Mar 18, 2021 |
O DONNELL MICHAEL J
|
Director |
Sell |
22.5
|
-4,387
|
-47.39%
|
✗
|
$228.8K |
|
Jan 11, 2021 |
Kupiec James William
|
Chief Clinical Dev. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2020 |
Dec 14, 2020 |
SCANNON PATRICK J MD PHD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2020 |
Dec 14, 2020 |
GUSSIN ROBERT Z
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2020 |
Dec 14, 2020 |
ROBERTSON SANFORD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 24, 2020 |
Sep 24, 2020 |
BARBIER REMI
|
CEO |
Buy |
72.5
|
+10,000
|
0.94%
|
✗
|
$95.9K |
| Sep 18, 2020 |
Sep 21, 2020 |
ROBERTSON SANFORD
|
Director |
Buy |
90.0
|
+36,281
|
4.14%
|
✗
|
$323.6K |
| Sep 17, 2020 |
Sep 17, 2020 |
Schoen Eric
|
CFO |
Buy |
95.0
|
+12,000
|
29.56%
|
✗
|
$84.4K |
| Sep 17, 2020 |
Sep 17, 2020 |
ROBERTSON SANFORD
|
Director |
Buy |
100.0
|
+213,719
|
32.25%
|
✗
|
$1.5M |